Quinine + Clindamycin

DRUG2 trials

Sponsors

Universiteit Antwerpen, Jean-Pierre Van geertruyden

Conditions

Malaria

Phase 3

Impact of Artemisinin-based Combination Therapy and Quinine on Treatment Failure and Resistance in Uncomplicated Malaria

CompletedNCT01374581

Universiteit AntwerpenMalaria

Start: 2012-05-31End: 2014-06-30Updated: 2014-10-22

Unknown Phase

An RCT to measure the impact of retreatment with artemisinin-based combination on malaria incidence and resistant strains selection

RecruitingPACTR201203000351114

Jean-Pierre Van geertruydenMalaria

Start: 2012-03-01Target: 310Updated: 2026-01-27

Related Papers

Efficacy and safety of re-treatment with the same artemisinin-based combination treatment (ACT) compared with an alternative ACT and quinine plus clindamycin after failure of first-line recommended ACT (QUINACT): a bicentre, open-label, phase 3, randomised controlled trial.

2016-11-1115 citations

Uncomplicated Clinical Malaria Features, the Efficacy of Artesunate-Amodiaquine and Their Relation with Multiplicity of Infection in the Democratic Republic of Congo

PLoS ONE2016-06-0922 citations

Impact of retreatment with an artemisinin-based combination on malaria incidence and its potential selection of resistant strains: study protocol for a randomized controlled clinical trial.

2013-09-2311 citations